Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 34, Issue 3, Pages -
Publisher
American Society for Microbiology
Online
2021-05-11
DOI
10.1128/cmr.00299-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2
- (2021) Helena Winstone et al. JOURNAL OF VIROLOGY
- Causes of death and comorbidities in hospitalized patients with COVID-19
- (2021) Sefer Elezkurtaj et al. Scientific Reports
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
- (2021) Ke Zhang et al. Science Advances
- Novel Wuhan (2019-nCoV) Coronavirus
- (2020) W. Graham Carlos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Fengxiang Song et al. RADIOLOGY
- The COVID‐19 epidemic
- (2020) Thirumalaisamy P. Velavan et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
- (2020) Hao Xu et al. International Journal of Oral Science
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- We shouldn’t worry when a virus mutates during disease outbreaks
- (2020) Nathan D. Grubaugh et al. Nature Microbiology
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
- (2020) Bolin Wang et al. Aging-US
- Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
- (2020) De Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- (2020) Achille Aouba et al. ANNALS OF THE RHEUMATIC DISEASES
- Should we try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
- (2020) Solomon Habtemariam et al. ARCHIVES OF MEDICAL RESEARCH
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- (2020) Alba Grifoni et al. Cell Host & Microbe
- Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
- (2020) Annsea Park et al. Cell Host & Microbe
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
- (2020) Joan C. Smith et al. DEVELOPMENTAL CELL
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Extra-respiratory manifestations of COVID-19
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
- (2020) Valeria Gaspari et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Type I IFN immunoprofiling in COVID-19 patients
- (2020) Sophie Trouillet-Assant et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19: Evidence of the Eye
- (2020) Yueyang Zhong et al. JOURNAL OF INFECTION
- Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis
- (2020) Jieyun Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia
- (2020) Guangchang Pei et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kawasaki-like disease: emerging complication during the COVID-19 pandemic
- (2020) Russell M Viner et al. LANCET
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- COVID-19 and Italy: what next?
- (2020) Andrea Remuzzi et al. LANCET
- An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
- (2020) Lucio Verdoni et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
- (2020) Ping Liu et al. PLoS Pathogens
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
- (2020) Meng-Yuan Li et al. Infectious Diseases of Poverty
- Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
- (2020) Adnan Shah Frontiers in Immunology
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Coronavirus disease 2019 (COVID-19): A literature review
- (2020) Harapan Harapan et al. Journal of Infection and Public Health
- COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
- (2020) Elena Ciaglia et al. Frontiers in Pediatrics
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral activities of type I interferons to SARS-CoV-2 infection
- (2020) Emily Mantlo et al. ANTIVIRAL RESEARCH
- Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
- (2020) Violetta Opoka-Winiarska et al. BMC Medicine
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
- (2020) Elizabeth Whittaker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
- (2020) Bruna G G Pinto et al. JOURNAL OF INFECTIOUS DISEASES
- Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation
- (2020) Dong Yang et al. JOURNAL OF INFECTIOUS DISEASES
- The cytokine storm and COVID‐19
- (2020) Biying Hu et al. JOURNAL OF MEDICAL VIROLOGY
- Central nervous system manifestations of COVID-19: A systematic review
- (2020) Ali A. Asadi-Pooya et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
- (2020) Zulvikar Syambani Ulhaq et al. MEDICINA CLINICA
- In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
- (2020) Inga-Marie Schaefer et al. MODERN PATHOLOGY
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
- (2020) Seyed Sina Naghibi Irvani et al. Trials
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
- (2020) Eddy Fan et al. Lancet Respiratory Medicine
- The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
- (2020) Zaid Abassi et al. Frontiers in Immunology
- Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
- (2020) Chaofu Wang et al. EBioMedicine
- SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts
- (2020) Ting Shu et al. VIROLOGICA SINICA
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
- (2020) Enrico Capochiani et al. Frontiers in Medicine
- Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study
- (2020) Patrick Davies et al. Lancet Child & Adolescent Health
- SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response
- (2020) Jessie Huang et al. Cell Stem Cell
- SARS-CoV-2 transmission dynamics should inform policy
- (2020) Muge Cevik et al. CLINICAL INFECTIOUS DISEASES
- Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
- (2020) Mengfei Chen et al. EUROPEAN RESPIRATORY JOURNAL
- Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
- (2020) Xiuhong Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
- (2020) Kumari G. Lokugamage et al. JOURNAL OF VIROLOGY
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
- (2020) Alessandro Gozzetti et al. LEUKEMIA
- Measurement of filtration efficiencies of healthcare and consumer materials using modified respirator fit tester setup
- (2020) Kenneth D. Long et al. PLoS One
- The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- (2020) Jin-Yan Li et al. VIRUS RESEARCH
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
- (2020) Yoriyuki Konno et al. Cell Reports
- SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs
- (2020) Yuan-Qin Min et al. Frontiers in Microbiology
- Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
- (2020) Mar Masiá et al. EBioMedicine
- A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process
- (2020) Rachel Harwood et al. Lancet Child & Adolescent Health
- Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
- (2020) Guoli Shi et al. EMBO JOURNAL
- Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients
- (2020) Ahmed Saleh et al. IMMUNOLOGICAL INVESTIGATIONS
- Risk factors for prolonged viral clearance in adult patients with COVID-19 in Beijing, China: A prospective observational study
- (2020) Jian Xue et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
- (2020) Carina Conceicao et al. PLOS BIOLOGY
- COVID-19 pneumonia and the appropriate use of antibiotics
- (2020) Amy Sarah Ginsburg et al. Lancet Global Health
- NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
- (2020) Ralf Kircheis et al. Frontiers in Immunology
- Severe acute respiratory syndrome coronavirus spike protein counteracts BST2‐mediated restriction of virus‐like particle release
- (2019) Shiu‐Mei Wang et al. JOURNAL OF MEDICAL VIROLOGY
- A review of sarilumab for the treatment of rheumatoid arthritis
- (2018) Eun Bong Lee Immunotherapy
- Angiotensin-converting enzyme in innate and adaptive immunity
- (2018) Kenneth E. Bernstein et al. Nature Reviews Nephrology
- Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis
- (2018) Carlos Castaño-Rodriguez et al. mBio
- SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death
- (2018) Yuan Yue et al. Cell Death & Disease
- The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
- (2018) Chandini Raina MacIntyre et al. BMC INFECTIOUS DISEASES
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity
- (2017) James Brett Case et al. JOURNAL OF VIROLOGY
- The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination
- (2017) Yong Hu et al. JOURNAL OF VIROLOGY
- The interplay between Angiotensin II, TLR4 and hypertension
- (2017) Vinicia Campana Biancardi et al. PHARMACOLOGICAL RESEARCH
- Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
- (2017) Xufang Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin (IL-6) Immunotherapy
- (2017) Toshio Tanaka et al. Cold Spring Harbor Perspectives in Biology
- The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation
- (2017) Zhen Ding et al. Oncotarget
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination
- (2016) J.A. Otter et al. JOURNAL OF HOSPITAL INFECTION
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Activation of renin–angiotensin–aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats
- (2015) Yi-Ming Yuan et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference
- (2015) Justin K. Taylor et al. JOURNAL OF VIROLOGY
- To sense or not to sense viral RNA—essentials of coronavirus innate immune evasion
- (2014) Eveline Kindler et al. CURRENT OPINION IN MICROBIOLOGY
- Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2'-O-Methyltransferase Activity
- (2014) V. D. Menachery et al. JOURNAL OF VIROLOGY
- Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
- (2014) X. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex
- (2014) Xiaojuan Chen et al. Protein & Cell
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Adult haemophagocytic syndrome
- (2013) Manuel Ramos-Casals et al. LANCET
- BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface
- (2013) Shiu-Mei Wang et al. VIROLOGY
- Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
- (2012) Stephanie Bertram et al. PLoS One
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome
- (2011) Markus Braun-Falco et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
- (2011) I-Chueh Huang et al. PLoS Pathogens
- How tumour necrosis factor blockers interfere with tuberculosis immunity
- (2010) J. Harris et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Angiotensin II revisited: new roles in inflammation, immunology and aging
- (2010) Ariela Benigni et al. EMBO Molecular Medicine
- Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway
- (2010) I.-Y. Chen et al. JOURNAL OF VIROLOGY
- Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases
- (2010) M. A. Clementz et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ Complex
- (2009) Kam-Leung Siu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
- (2009) Elizabeth A. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
- (2009) Jean-Michel Dayer et al. RHEUMATOLOGY
- Interferon and cytokine responses to SARS-coronavirus infection
- (2008) Volker Thiel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation
- (2008) Bo Zhong et al. IMMUNITY
- Coronavirus Nonstructural Protein 16 Is a Cap-0 Binding Enzyme Possessing (Nucleoside-2'O)-Methyltransferase Activity
- (2008) E. Decroly et al. JOURNAL OF VIROLOGY
- Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats
- (2007) Q Dai et al. BRITISH JOURNAL OF PHARMACOLOGY
- SARS coronavirus accessory proteins
- (2007) Krishna Narayanan et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More